Willis Towers Watson (NASDAQ: WTW) executive awarded 12.6 RSUs

Rhea-AI Filing Summary

Gebauer Julie Jarecke reported acquisition or exercise transactions in this Form 4 filing.

WILLIS TOWERS WATSON PLC executive Julie Jarecke Gebauer, Pres.-Health, Wealth & Career, reported an award of 12.6282 restricted share units under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees. These units settle into Ordinary Shares on a 1:1 basis upon specified separation or death-related distribution events, bringing her total plan-related restricted share units to 5,626.3389.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Gebauer Julie Jarecke

Role Pres.-Health, Wealth & Career

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Unit F1, F2	12.6282	$0.00	$0.00

Holdings After Transaction: Restricted Share Unit — 5,626.3389 shares (Direct)

Footnotes (2)

1. F1. Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.
2. F2. Includes restricted share units credited to the participant's account by the Company pursuant to the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees (the "Plan") accrual formula, net of the units acquired pursuant to the participant's contribution under the Plan.

Key Figures

Restricted share units awarded: 12.6282 units Total restricted share units after award: 5626.3389 units Stated transaction price per unit: $0.0000 +3 more

6 metrics

Restricted share units awarded 12.6282 units Grant/award acquisition on 2026-08-13

Total restricted share units after award 5626.3389 units Plan-related units held following the reported transaction

Stated transaction price per unit $0.0000 Grant/award of restricted share units; price footnote-qualified

Underlying Ordinary Share nominal value $0.000304635 per share Nominal value of Willis Towers Watson Ordinary Shares

Separation settlement delay 6 months Units settle 6 months after separation from service, if earlier than death

Death settlement delay 30 days Units settle 30 days after death if earlier than separation-based date

Key Terms

Restricted Share Unit, Non-Qualified Stable Value Excess Plan, separation from service, Ordinary Shares, nominal value $0.000304635 per share

4 terms

Restricted Share Unit financial

"The reporting person received an award of 12.6282 Restricted Share Units."

A restricted share unit (RSU) is a promise by a company to give an employee a set number of company shares at a future date, typically after meeting time or performance conditions. For investors, RSUs matter because when they convert into actual shares they increase the number of shares outstanding (like unlocking more tickets in a game), which can dilute existing holders, and they align employee incentives with company performance, influencing behavior and long-term value.

Non-Qualified Stable Value Excess Plan financial

"Credited under the Willis Towers Watson Non-Qualified Stable Value Excess Plan."

separation from service financial

"Settlement occurs after the reporting person's separation from service or death."

Ordinary Shares, nominal value $0.000304635 per share financial

"Units settle into Ordinary Shares, nominal value $0.000304635 per share."

FAQ

What transaction did WTW executive Julie Jarecke Gebauer report on this Form 4?

Julie Jarecke Gebauer reported an award of 12.6282 restricted share units tied to Willis Towers Watson Ordinary Shares. These units were credited under the company’s Non-Qualified Stable Value Excess Plan for U.S. Employees according to the plan’s accrual formula.

How many Willis Towers Watson (WTW) restricted share units does the insider hold after this transaction?

After this award, the reporting person holds 5,626.3389 restricted share units under the Willis Towers Watson Non-Qualified Stable Value Excess Plan. This figure includes units credited under the plan’s accrual formula, net of units acquired through the participant’s contributions.

What is the settlement ratio for the WTW restricted share units reported in this filing?

The restricted share units settle into Willis Towers Watson Ordinary Shares on a 1:1 basis. Vested units convert into an equal number of Ordinary Shares, each with a nominal value of $0.000304635 per share, upon the plan’s specified distribution events.

When will the restricted share units for WTW’s Julie Jarecke Gebauer be settled into shares?

The vested units settle into Ordinary Shares on the first business day of the month Nasdaq is open following the earlier of six months after separation from service or 30 days after death, consistent with the plan’s distribution provisions.

Was the WTW Form 4 transaction a market purchase or sale of shares?

No market trade occurred; the Form 4 reports a grant/award acquisition of restricted share units with a stated price of $0.0000 per unit. The units were credited under the company’s Non-Qualified Stable Value Excess Plan for U.S. Employees.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/17/2026 - 04:05 PM Accepted by SEC EDGAR 08/17/2026 - 04:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gebauer Julie Jarecke

(Last) (First) (Middle)

C/O WILLIS GROUP LIMITED

51 LIME STREET

(Street)

LONDON EC3M 7DQ

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
WILLIS TOWERS WATSON PLC [ WTW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres.-Health, Wealth & Career

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Unit	(1)	08/13/2026		A		12.6282(2)		(1)	(1)	Ordinary Shares, nominal value $0.000304635 per share	12.6282	$0	5,626.3389	D

Explanation of Responses:

1. Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

2. Includes restricted share units credited to the participant's account by the Company pursuant to the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees (the "Plan") accrual formula, net of the units acquired pursuant to the participant's contribution under the Plan.

	/s/ Julie J. Gebauer by Gary Pang, Attorney-in-Fact (power of attorney previously filed)	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)